ASSOCIATIONS OF METABOLIC SUBTYPES OF METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE WITH RISK OF CARDIOVASCULAR MORTALITY AND ALL-CAUSE MORTALITY IN THE UNITED STATES

被引：0
|
作者：
Zeng, Guyu [1 ]
Wang, Peizhi [1 ]
Yuan, Jinqing [1 ]
机构：
[1] Fuwai Hosp, Beijing, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1453-207
引用
收藏
页码：1968 / 1968
页数：1
相关论文
共 50 条
  • [31] Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Zhou, Xiao-Dong
    Cai, Jingjing
    Targher, Giovanni
    Byrne, Christopher D.
    Shapiro, Michael D.
    Sung, Ki-Chul
    Somers, Virend K.
    Chahal, C. Anwar A.
    George, Jacob
    Chen, Li-Li
    Zhou, Yong
    Zheng, Ming-Hua
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [32] Association of Metabolic Dysfunction-Associated Fatty Liver Disease with Cognitive Impairment and All-Cause Dementia: A Comprehensive Review
    Kaya, Eda
    Yilmaz, Yusuf
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2024, 35 (02): : 76 - 82
  • [33] Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
    Bernhard, Johannes
    Galli, Lukas
    Speidl, Walter S.
    Krychtiuk, Konstantin A.
    CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
  • [34] Multiple vitamin co-exposure and mortality risk in metabolic dysfunction-associated fatty liver disease
    Wang Zilong
    Huang, Linxiang
    Wang, Xiaoxiao
    Jin, Rui
    Liu, Baiyi
    Liu, Feng
    Rao, Huiying
    JOURNAL OF HEPATOLOGY, 2023, 78 : S862 - S862
  • [35] Metabolic subtypes and all-cause and cardiovascular mortality in patients with type 1 diabetes
    Lithovius, R.
    Toppila, I.
    Harjutsalo, V.
    Forsblom, C.
    Groop, P. -H.
    Makinen, V. -P.
    DIABETOLOGIA, 2016, 59 : S543 - S544
  • [36] Impact of Thyroid Function on the Prevalence and Mortality of Metabolic Dysfunction-Associated Fatty Liver Disease
    Chen, Yu-ling
    Tian, Shen
    Wu, Juan
    Li, Hao
    Li, Shu
    Xu, Zhou
    Liang, Xin-yu
    Adhikari, Vishnu Prasad
    Xiao, Jun
    Song, Jing-yu
    Ma, Chen-yu
    She, Rui-ling
    Li, Zhao-xing
    Wu, Kai-nan
    Kong, Ling-quan
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (07): : E434 - E443
  • [37] FATTY LIVER ITSELF IN MAFLD DOES NOT INCREASE ALL-CAUSE MORTALITY IN INDIVIDUALS WITH METABOLIC DYSFUNCTION
    Kwak, Min-Sun
    Kim, Hyunseok
    Jiang, Z. Gordon Gordon
    Noureddin, Mazen
    Yang, Ju Dong
    HEPATOLOGY, 2023, 78 : S960 - S961
  • [38] Association of neutrophil-to-lymphocyte ratio and risk of all-cause and cardiovascular mortality in adults with metabolic dysfunction-associated steatotic liver disease: a population-based cohort study
    Zhang, Ying
    Zhang, Ai-Hua
    Li, Rong-Li
    Li, Wen-Jun
    Liu, Yun
    Li, Teng
    FRONTIERS IN MEDICINE, 2024, 11
  • [39] Associations of an overall healthy lifestyle with the risk of metabolic dysfunction-associated fatty liver disease
    Yuan, Caimei
    Zhang, Chengjing
    Geng, Xin
    Feng, Chengwu
    Su, Yang
    Wu, Yinfan
    Wang, Ying
    Chen, Li
    Ding, Qiurong
    Voortman, Trudy
    Wang, Hongyang
    Zong, Geng
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [40] Trends in prevalence and all-cause mortality of metabolic dysfunction-associated fatty liver disease among adults in the past three decades: Results from the NHANES study
    Xie, Zhi-Qin
    Li, Hong-Xia
    Wang, Bing-Kun
    Yang, Zhao-Ming
    Zhang, Zi-Yu
    Tan, Wen-Liang
    Li, Wen-Xin
    Wang, Qing-Bin
    Yang, Lei
    Zhuang, Hong-Kai
    Tang, Chen-Wei
    Shang, Chang-Zhen
    Chen, Ya-Jin
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 110 : 62 - 70
12345